MedTrace Logo

WRAP North America

NCT06807099 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2026-02-23

No results posted yet for this study

Summary

The goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with standard of care up to 3-years post-procedure.

Conditions

  • Venous Stenosis
  • Venous Occlusion

Interventions

DEVICE

Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE)

Target Lesion treated with WRAPSODY CIE

Sponsors & Collaborators

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2027-12-31
Completion
2030-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06807099 on ClinicalTrials.gov